Project Grant R21AG083558
Award Date
9/1/23
Completion Date
8/31/25
Dollars Obligated
$380K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Phoenix, AZ 85012, USA
Similar Awards
The National Institute on Aging (NIA) awarded a $471,635 Project Grant (CFDA 93.866 - Aging Research) to the Arizona Veterans Research And Education Foundation, a non-profit research organization, to conduct studies on the role of the peptide Medin in vascular aging and its relationship to dementia disorders. Key products and services to be delivered under this grant include: Genome-wide CRISPR/Cas9 screening in endothelial cells to identify genes and biological pathways involved in...
This $356,174 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to determine the efficacy of an active immunization strategy in preserving cognitive and neural function by slowing the formation of amyloid-beta (Aβ) or tau proteins in the brain, which are significant contributors to neurodegenerative diseases like Alzheimer's. The key activities supported under this 2-year grant include: 1) prophylactically immunizing 5XFAD and hTau transgenic mouse...
This $682,000 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to The Roskamp Institute, Inc. will investigate the influence of microglial cell depletion and repopulation on aducanumab-induced amyloid-related imaging abnormalities (ARIA) and vascular lesions in APOE4 carriers with Alzheimer's disease (AD). The goal is to reveal whether activated microglia-mediated cerebrovascular inflammation contributes to APOE4-mediated ARIA events following aducanumab...
This $794,341 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) is supporting research to investigate the role of cellular senescence and blood-brain barrier dysfunction in Alzheimer's disease progression. The research project, led by the University of Illinois, aims to elucidate how viral and bacterial pathogens can initiate blood-brain barrier dysfunction and cellular senescence, which in turn promote neuroinflammation and Alzheimer's disease...
This Project Grant award, funded by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866), supports research to evaluate the efficacy of a novel therapeutic approach targeting neuroinflammation for protecting against brain aging and Alzheimer's disease-related pathology. The $679,424 award will enable comprehensive preclinical studies to test the ability of NF-κB/NLRP3-targeted nanoligomers to reduce neuroinflammation and protect cognitive function in...
The National Institute on Aging (NIA) awarded a $2,244,471 Project Grant under CFDA 93.866 (Aging Research) to Oregon Health & Science University (OHSU) to develop a first-in-class, CNS-penetrant small molecule agonist for G protein-coupled receptor 39 (GPR39) as a potential treatment for vascular cognitive impairment and dementia (VCID). The 3-year project from September 2023 to August 2026 will use in vitro and in vivo assays to identify lead compounds, determine their safety and...
This federal Project Grant award from the National Institute on Aging (NIA), under the Aging Research program (CFDA 93.866), provides $831,583 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct research on characterizing microvascular impairment in adults with elevated genetic risk for Alzheimer's disease. The long-term goal of the work is to elucidate the physiological mechanisms through which the APOE-E4 genetic variant contributes to...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) to the University of Texas Health Science Center at Houston (UTHealth) provides $766,133 to study the mechanisms underlying Amyloid-Related Imaging Abnormalities (ARIA) following anti-amyloid immunotherapy for Alzheimer's disease. The key products to be delivered through this 5-year project include: Determining the elimination pathway and clearance mechanism of chimeric anti-amyloid antibodies...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to Rutgers, The State University of New Jersey, totals $431,750 and aims to identify molecular features associated with vascular alterations in aging. The primary objectives are to: Isolate and characterize peptide ligands targeting vascular endothelial cells (VECs) in young versus aged mice in vivo. Identify peptide ligands specific to senescent VEC receptors through further biopanning. Validate the...
This $1,010,081 federal Project Grant award from the National Institute on Aging (under CFDA 93.866 - Aging Research) supports a multi-year research project by Emory University focused on identifying potential "goldilocks zone" immune modulatory therapies for Alzheimer's disease. The overarching goal is to systematically evaluate the liabilities and benefits of different immune system manipulations in preclinical models of amyloid pathology, with the aim of finding interventions that...